Viemed Healthcare (VMD) Cash from Investing Activities (2018 - 2026)

Viemed Healthcare has reported Cash from Investing Activities for 9 years, with the latest figure at -$5.5 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 35.7% year-over-year to -$5.5 million; the trailing twelve-month figure through Mar 2026 stood at -$47.1 million (down 39.15% YoY), and the FY2025 full-year result was -$50.2 million, down 63.41% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at -$5.5 million, up from -$7.6 million in the prior quarter.
• The five-year high for Cash from Investing Activities was -$1.7 million in Q2 2025, with the low at -$32.3 million in Q3 2025.
• Historically, Cash from Investing Activities has averaged -$9.6 million across 5 years, with a median of -$7.4 million in 2022.
• The largest YoY upside for Cash from Investing Activities was 84.53% in 2025 against a maximum downside of 549.97% in 2025.
• Viemed Healthcare's Cash from Investing Activities stood at -$7.4 million in 2022, then fell by 1.56% to -$7.5 million in 2023, then decreased by 22.75% to -$9.2 million in 2024, then advanced by 17.24% to -$7.6 million in 2025, then climbed by 27.94% to -$5.5 million in 2026.
• The last three Cash from Investing Activities figures came in at -$5.5 million (Q1 2026), -$7.6 million (Q4 2025), and -$32.3 million (Q3 2025), per Business Quant data.